Does GEMFIBROZIL Cause Off label use? 19 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Off label use have been filed in association with GEMFIBROZIL (Gemfibrozil). This represents 1.7% of all adverse event reports for GEMFIBROZIL.
19
Reports of Off label use with GEMFIBROZIL
1.7%
of all GEMFIBROZIL reports
3
Deaths
6
Hospitalizations
How Dangerous Is Off label use From GEMFIBROZIL?
Of the 19 reports, 3 (15.8%) resulted in death, 6 (31.6%) required hospitalization, and 1 (5.3%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMFIBROZIL. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does GEMFIBROZIL Cause?
Drug hypersensitivity (242)
Drug ineffective (77)
Rhabdomyolysis (63)
Fatigue (60)
Drug interaction (59)
Myalgia (58)
Nausea (54)
Acute kidney injury (52)
Diarrhoea (43)
Rash (41)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which GEMFIBROZIL Alternatives Have Lower Off label use Risk?
GEMFIBROZIL vs GEMTUZUMAB OZOGAMICIN
GEMFIBROZIL vs GEMZAR
GEMFIBROZIL vs GENTAMICIN
GEMFIBROZIL vs GEODON
GEMFIBROZIL vs GILENYA